Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2
Bariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≧ 35 kg/m2. Mounting evidence also shows that metabolic surgery is effective for T2DM with BMI < 35 kg/m2. To evaluate current status of metabolic surgery, we...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Journal of Obesity |
| Online Access: | http://dx.doi.org/10.1155/2012/147256 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556081521360896 |
|---|---|
| author | Hideharu Shimizu Poochong Timratana Philip R. Schauer Tomasz Rogula |
| author_facet | Hideharu Shimizu Poochong Timratana Philip R. Schauer Tomasz Rogula |
| author_sort | Hideharu Shimizu |
| collection | DOAJ |
| description | Bariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≧ 35 kg/m2. Mounting evidence also shows that metabolic surgery is effective for T2DM with BMI < 35 kg/m2. To evaluate current status of metabolic surgery, we reviewed the available clinical studies which described surgical treatment for T2DM with mean BMI < 35 kg/m2. 18 studies with 477 patients were identified. 30% of the patients was insulin users. The follow-up period ranged from 6 to 216 months. The weight loss effect was reasonable, not excessive. Mean BMI decreased from 30.4 to 24.8 kg/m2. Remission of T2DM was achieved in 64.7% of the patients with fasting plasma glucose and glycated hemoglobin approaching slightly above normal range. Clinical T2DM status was an important factor when selecting the eligible candidates for metabolic surgery. Postoperative complication rate of 10.3% with mortality of 0% in the studies has been acceptable. Even though it would be premature at this point to state that metabolic surgery is an accepted treatment option for T2DM with BMI < 35 kg/m2, it is clear that a high proportion of T2DM patients will derive substantial benefit from metabolic surgery. |
| format | Article |
| id | doaj-art-a3059a63d9604d9fb49cd312ed411310 |
| institution | Kabale University |
| issn | 2090-0708 2090-0716 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Obesity |
| spelling | doaj-art-a3059a63d9604d9fb49cd312ed4113102025-02-03T05:46:29ZengWileyJournal of Obesity2090-07082090-07162012-01-01201210.1155/2012/147256147256Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2Hideharu Shimizu0Poochong Timratana1Philip R. Schauer2Tomasz Rogula3M61 Cleveland Clinic, Bariatric and Metabolic Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USAM61 Cleveland Clinic, Bariatric and Metabolic Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USAM61 Cleveland Clinic, Bariatric and Metabolic Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USAM61 Cleveland Clinic, Bariatric and Metabolic Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USABariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≧ 35 kg/m2. Mounting evidence also shows that metabolic surgery is effective for T2DM with BMI < 35 kg/m2. To evaluate current status of metabolic surgery, we reviewed the available clinical studies which described surgical treatment for T2DM with mean BMI < 35 kg/m2. 18 studies with 477 patients were identified. 30% of the patients was insulin users. The follow-up period ranged from 6 to 216 months. The weight loss effect was reasonable, not excessive. Mean BMI decreased from 30.4 to 24.8 kg/m2. Remission of T2DM was achieved in 64.7% of the patients with fasting plasma glucose and glycated hemoglobin approaching slightly above normal range. Clinical T2DM status was an important factor when selecting the eligible candidates for metabolic surgery. Postoperative complication rate of 10.3% with mortality of 0% in the studies has been acceptable. Even though it would be premature at this point to state that metabolic surgery is an accepted treatment option for T2DM with BMI < 35 kg/m2, it is clear that a high proportion of T2DM patients will derive substantial benefit from metabolic surgery.http://dx.doi.org/10.1155/2012/147256 |
| spellingShingle | Hideharu Shimizu Poochong Timratana Philip R. Schauer Tomasz Rogula Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2 Journal of Obesity |
| title | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2 |
| title_full | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2 |
| title_fullStr | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2 |
| title_full_unstemmed | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2 |
| title_short | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m2 |
| title_sort | review of metabolic surgery for type 2 diabetes in patients with a bmi 35 kg m2 |
| url | http://dx.doi.org/10.1155/2012/147256 |
| work_keys_str_mv | AT hideharushimizu reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 AT poochongtimratana reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 AT philiprschauer reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 AT tomaszrogula reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 |